| A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions A Latouche, A Allignol, J Beyersmann, M Labopin, JP Fine Journal of clinical epidemiology 66 (6), 648-653, 2013 | 451 | 2013 |
| Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis FC Bidard, S Michiels, S Riethdorf, V Mueller, LJ Esserman, A Lucci, ... JNCI: Journal of the National Cancer Institute 110 (6), 560-567, 2018 | 265 | 2018 |
| Simulating competing risks data in survival analysis J Beyersmann, A Latouche, A Buchholz, M Schumacher Statistics in medicine 28 (6), 956-971, 2009 | 258 | 2009 |
| Relative index of inequality and slope index of inequality: a structured regression framework for estimation M Moreno-Betancur, A Latouche, G Menvielle, AE Kunst, G Rey Epidemiology 26 (4), 518-527, 2015 | 242 | 2015 |
| Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation: Presented in part at the Annual Meeting … V Rocha, RF Franco, R Porcher, H Bittencourt, WA Silva Jr, A Latouche, ... Blood, The Journal of the American Society of Hematology 100 (12), 3908-3918, 2002 | 242 | 2002 |
| Effectiveness of two year balance training programme on prevention of fall induced injuries in at risk women aged 75-85 living in community: Ossébo randomised controlled trial F El-Khoury, B Cassou, A Latouche, P Aegerter, MA Charles, ... Bmj 351, 2015 | 165 | 2015 |
| Competing risks regression for clustered data B Zhou, J Fine, A Latouche, M Labopin Biostatistics 13 (3), 371-383, 2012 | 152 | 2012 |
| A review of the use of time‐varying covariates in the Fine‐Gray subdistribution hazard competing risk regression model PC Austin, A Latouche, JP Fine Statistics in medicine 39 (2), 103-113, 2020 | 117 | 2020 |
| Sample size formula for proportional hazards modelling of competing risks A Latouche, R Porcher, S Chevret Statistics in medicine 23 (21), 3263-3274, 2004 | 116 | 2004 |
| Competing risks regression for stratified data B Zhou, A Latouche, V Rocha, J Fine Biometrics 67 (2), 661-670, 2011 | 113 | 2011 |
| Misspecified regression model for the subdistribution hazard of a competing risk A Latouche, V Boisson, S Chevret, R Porcher Statistics in medicine 26 (5), 965-974, 2007 | 107 | 2007 |
| Predictiveness curves in virtual screening C Empereur-Mot, H Guillemain, A Latouche, JF Zagury, V Viallon, ... Journal of cheminformatics 7, 1-17, 2015 | 104 | 2015 |
| Comparative analysis of durable responses on immune checkpoint inhibitors versus other systemic therapies: a pooled analysis of phase III trials E Pons-Tostivint, A Latouche, P Vaflard, F Ricci, D Loirat, S Hescot, ... JCO Precision Oncology 3, 1-10, 2019 | 95 | 2019 |
| Circulating tumor cells in early breast cancer L Thery, A Meddis, L Cabel, C Proudhon, A Latouche, JY Pierga, ... JNCI cancer spectrum 3 (2), pkz026, 2019 | 87 | 2019 |
| Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate? DJ Biau, A Latouche, R Porcher Clinical Orthopaedics and Related Research® 462, 229-233, 2007 | 87 | 2007 |
| A note on including time‐dependent covariate in regression model for competing risks data A Latouche, R Porcher, S Chevret Biometrical Journal: Journal of Mathematical Methods in Biosciences 47 (6 …, 2005 | 82 | 2005 |
| Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points … F Bonnetain, B Bonsing, T Conroy, A Dousseau, B Glimelius, ... European journal of cancer 50 (17), 2983-2993, 2014 | 75 | 2014 |
| Sample size calculations in the presence of competing risks A Latouche, R Porcher Statistics in medicine 26 (30), 5370-5380, 2007 | 73 | 2007 |
| Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa SG Mahiane, C Legeai, D Taljaard, A Latouche, A Puren, A Peillon, ... Aids 23 (3), 377-383, 2009 | 72 | 2009 |
| A 3-year prognostic score for adults with cystic fibrosis L Nkam, J Lambert, A Latouche, G Bellis, PR Burgel, MN Hocine Journal of Cystic Fibrosis 16 (6), 702-708, 2017 | 65 | 2017 |
Grégoire ReyINSERM在 inserm.fr 的电子邮件经过验证
